By Kelly Cloonan
Kestra Medical Technologies posted higher revenue in its fiscal third quarter, in its first quarterly results since going public.
The wearable medical device company posted a loss of $21.5 million, or $1.25 a share, for the quarter ended Jan. 31, compared with a loss of $21.6 million, or $1.18 a share, a year earlier.
Revenue rose 82% to $15.1 million, in line with analyst estimates, compared with $8.3 million a year ago.
New account activations and a higher wallet share at existing customers drove the revenue growth, the company said. A higher mix of in-network patients and improvements in revenue cycle management capabilities also helped boost sales.
For fiscal 2025, Kestra expects revenue of $58 million to $58.5 million, in line with analyst estimates of $58.2 million.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 14, 2025 16:40 ET (20:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.